*Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN; and †Mental Health Cooperative, Inc, Nashville, TN.
Conflicts of Interest and Source of Funding: Funding for the study was provided by an investigator-initiated grant from Janssen Pharmaceutica. In the past, WVB has received grant/research support from Cephalon, Inc, and has served on speaker bureaus for Janssen Pharmaceutica and Pfizer, Inc. RCS has received grant/research support from Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutica, Pfizer, Sanofi-Aventis, Wyeth-Ayerst Laboratories, AstraZeneca Pharmaceuticals, and Abbott Laboratories; has served as a paid consultant for Pfizer, Janssen Pharmaceutica, and Sierra Neuropharmaceuticals; and has served on the speakers’ bureau for Bristol-Myers Squibb, Eli Lilly and Company, Janssen Pharmaceutica, Pfizer, GlaxoSmithKline, Wyeth-Ayerst Laboratories, and Abbott Laboratories. RAE, AL, NB, and TDP have no potential sources of conflict of interest to disclose.
Address correspondence and reprint requests to William V. Bobo, MD, Suite 2600, 1500 21st Ave S, Village at Vanderbilt, Nashville, TN 37212; E-mail: [email protected]